GALCANEZUMAB
galcanezumab 120 mg/mL injection, 1 mL pen device
GALCANEZUMAB (12469G)
12469G
Body System:
Manner of administration:Injection
Restriction 14563
Indication: Treatment-resistant migraine
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $523.36 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Emgality | |||||